<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ateroskleroz</journal-id><journal-title-group><journal-title xml:lang="ru">Атеросклероз</journal-title><trans-title-group xml:lang="en"><trans-title>Ateroscleroz</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-256X</issn><issn pub-type="epub">2949-3633</issn><publisher><publisher-name>НИИТПМ-филиал ИЦиГ СО РАН</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">ateroskleroz-20</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>ФИБРИЛЛЯЦИЯ ПРЕДСЕРДИЙ: РАСПРОСТРАНЕННОСТЬ И КРОСС-СЕКЦИОННЫЕ ДЕТЕРМИНАНТЫ В ПОПУЛЯЦИИ НОВОСИБИРСКА (КОГОРТA HAPIEE)</article-title><trans-title-group xml:lang="en"><trans-title>ATRIAL FIBRILLATION: PREVALENCE AND CROSS-SECTIONAL DETERMINANTS IN NOVOSIBIRSK POPULATION (HAPIEE COHORT, 9255 PARTICIPANTS)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шапкина</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Shapkina</surname><given-names>M. ..</given-names></name></name-alternatives><email xlink:type="simple">marina-shapkina@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рябиков</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Ryabikov</surname><given-names>A. ..</given-names></name></name-alternatives><email xlink:type="simple">a_ryabikov@hotmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воронина</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Voronina</surname><given-names>E. ..</given-names></name></name-alternatives><email xlink:type="simple">voroninacat@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Маздорова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Mazdorova</surname><given-names>E. ..</given-names></name></name-alternatives><email xlink:type="simple">mazdorova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Щербакова</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Sherbakova</surname><given-names>L. ..</given-names></name></name-alternatives><email xlink:type="simple">sherbakova@iimed.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бобак</surname><given-names>М.</given-names></name><name name-style="western" xml:lang="en"><surname>Bobak</surname><given-names>M. ..</given-names></name></name-alternatives><email xlink:type="simple">m.bobak@ucl.ac.uk</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малютина</surname><given-names>С. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Malyutina</surname><given-names>S. ..</given-names></name></name-alternatives><email xlink:type="simple">smalyutina@hotmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт терапии и профилактической медицины»</institution></aff><aff xml:lang="en"><institution>FSBSE «Scientific Research institute of therapy and preventive medicine»</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Университетский колледж Лондона</institution></aff><aff xml:lang="en"><institution>University of London</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>27</day><month>09</month><year>2019</year></pub-date><volume>12</volume><issue>3</issue><fpage>22</fpage><lpage>27</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шапкина М.Ю., Рябиков А.Н., Воронина Е.В., Маздорова Е.В., Щербакова Л.В., Бобак М..., Малютина С.К., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Шапкина М.Ю., Рябиков А.Н., Воронина Е.В., Маздорова Е.В., Щербакова Л.В., Бобак М., Малютина С.К.</copyright-holder><copyright-holder xml:lang="en">Shapkina M..., Ryabikov A..., Voronina E..., Mazdorova E..., Sherbakova L..., Bobak M..., Malyutina S...</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://ateroskleroz.elpub.ru/jour/article/view/20">https://ateroskleroz.elpub.ru/jour/article/view/20</self-uri><abstract><p>Цель исследования: изучить распространенность и детерминанты ФП по данным кросс-секционного исследования в популяции 45-69 лет Новосибирска. Материалы и методы: обследована случайная популяционная выборка мужчин и женщин 45-69 лет (n=9360), проект HAPIEE, Новосибирск. Использовались стандартные эпидемиологические методы исследования. В рамках факультативного раздела выполнена электрокардиография участников с оценкой по Миннесотскому коду (n=9255). Они были включены в настоящий анализ ФП (грант РНФ 14-45-0030). Результаты: в изученной популяционной выборке распространенность ФП составила 1,6% (1,1% для женщин и 2,1% для мужчин). Частота ФП увеличивалась с возрастом: от 0,3% в возрастной группе 45-49 лет для обоих полов, до 4,0% у мужчин и 2,8% у женщин в старшей возрастной группе (65-69 лет) (p&lt;0.001). При нестандартизованной оценке, ФП у мужчин ассоциировалась со старшим возрастом, частотой сердечных сокращений (ЧСС) (р&lt;0,001), диастолическим артериальным давлением (р=0,003), индексом массы тела (ИМТ) (р&lt;0,001), наличием сердечно-сосудистых заболеваний (ССЗ), артериальной гипертензии (АГ) (р&lt;0,001) и сахарного диабета (СД) (р=0,002). При сопоставлении лабораторных показателей лица с ФП имели более низкие уровни общего холестерина (ОХС) (р=0,001), холестерина липопротеидов низкой плотности (ХСЛНП) (р=0,005) и более высокий уровень гамма-глютамилтранспептидазы (ГГТ) (р&lt;0,001). Достоверных различий по частоте и дозе потребления алкоголя в связи с ФП не выявлено. У женщин получены аналогичные результаты по исследуемым факторам риска и кардиометаболическим заболеваниям. В мультивариантном анализе ФП у мужчин позитивно ассоциировалась с возрастом, ЧСС, ИМТ (p&lt;0.001) и негативно - с уровнем триглицеридов (p=0.019) и ХСЛНП крови (p=0.001). У женщин выявлена положительная ассоциация ФП с возрастом, ЧСС, ИМТ (p&lt;0.001), уровнем ГГТ (p=0.002) и негативная - с уровнем ХСЛНП (p&lt;0.001). Выводы: в популяционной выборке 45-69 лет г. Новосибирска распространенность ФП составила 1,6%, что близко к показателям в других популяциях. Детерминантами ФП были ССЗ, АГ, СД, ЧСС, ИМТ, увеличение возраста (для обоих полов) и ГГТ у женщин. Мы не обнаружили прямой связи между ФП и атерогенными показателями липидного профиля; эти результаты, вероятно, связаны с модулирующем вкладом кардиометаболических факторов.</p></abstract><trans-abstract xml:lang="en"><p>Objectives: to investigate the prevalence and determinants of AF in cross-sectional study in a population sample 45-69 age (Novosibirsk). Materials and methods: a random population sample of men and women 45-69 years old (y. o.) (n=9360) was examined in Novosibirsk (project HAPIEE). We used standard epidemiological methods. As optional study ECG was registered participants and estimated by Minnesota code (n=9255). They were included for current analysis (grant RSF 14-45-0030). Results: in studied population sample the prevalence of AF was 1.6% (1.1% in women and 2.1% in men). The frequency of AF increased with age: from 0.3% in age group of 45-49 y. o. in both sexes to 4.0% in men and 2.8% in women in the oldest age group (65-69 y. o.), p&lt;0.001. In unadjusted analysis, in men AF was associated with elder age, heart rate (HR) (р&lt;0,001), diastolic blood pressure (р=0,003), body mass index (BMI) (р&lt;0,001), presence of cardiovascular disease (CVD), hypertension (HT) (р&lt;0,001) and diabetes mellitus (DM) (р=0,002). When we have compared laboratory parameters, the patients with AF had lower level of total cholesterol (TC) (р=0,001), low-density lipoprotein cholesterol (LDL-C) (р=0,005) and higher level of gamma-glutamyltranspeptidase (GGT) (p &lt;0.001). The significant difference of alcohol consumption measures in relation to AF we did not identified in population sample. In women were similar results in the studied risk factors and cardiometabolic diseases. In multivariate regression, AF in men was positively associated with age, HR, BMI (p&lt;0.001) and negatively related to level of triglycerides (p=0.019) and LDL-C level (p=0.001). Women had a positive association of AF with age, HR, BMI (p&lt;0.001), GGT (p=0.002) and negative - to LDL-C level (p&lt;0.001). Conclusions: in a population sample 45-69 y. o. of Novosibirsk the prevalence of AF was 1.6%, which is close to indicators in other populations. Determinants of AF were CVD, HT, DM, HR, BMI, increasing age (for both sexes) and GGT level in women. We did not find the direct relationship between AF and the atherogenic lipid profile; these results are likely to be associated with the modulating contribution of cardiometabolic factors.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>фибрилляция предсердий</kwd><kwd>распространенность</kwd><kwd>детерминанты</kwd><kwd>артериальная гипертензия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>atrial fibrillation</kwd><kwd>the prevalence</kwd><kwd>determinants</kwd><kwd>hypertension</kwd><kwd>cross-sectional study</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Go A. S., Hylek E. M., Phillips K. A. et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study // JAMA. 2001. Vol. 285, N15. Р. 2370-2375.</mixed-citation><mixed-citation xml:lang="en">Go A. S., Hylek E. M., Phillips K. A. et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study // JAMA. 2001. Vol. 285, N15. Р. 2370-2375.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Мерцательная аритмия / Ред. С. А. Бойцова. Санкт-Петербург: «ЭЛБИ-СПБ», 2001. 335 с.</mixed-citation><mixed-citation xml:lang="en">Мерцательная аритмия / Ред. С. А. Бойцова. Санкт-Петербург: «ЭЛБИ-СПБ», 2001. 335 с.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Wolf P. A., Abbott R. D., Kannel W. B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991. Vol.22. P. 983- 988.</mixed-citation><mixed-citation xml:lang="en">Wolf P. A., Abbott R. D., Kannel W. B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991. Vol.22. P. 983- 988.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Knecht S., Oelschlager C., Duning T., et al. Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy // Eur Heart J. 2008. Vol. 29. P. 2125-2132.</mixed-citation><mixed-citation xml:lang="en">Knecht S., Oelschlager C., Duning T., et al. Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy // Eur Heart J. 2008. Vol. 29. P. 2125-2132.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Диагностика и лечение фибрилляции предсердий. Рекомендации РКО, ВНОА, АССХ / Ред. И. С. Явелов. Москва, 2012. 100 с.</mixed-citation><mixed-citation xml:lang="en">Диагностика и лечение фибрилляции предсердий. Рекомендации РКО, ВНОА, АССХ / Ред. И. С. Явелов. Москва, 2012. 100 с.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Peasey A., Bobak M., Kubinova R., Malyutina S., et al. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: Rationale and design of the HAPIEE study // BMC Public Health. 2006. Vol. 18, N.6. P. 255-265.</mixed-citation><mixed-citation xml:lang="en">Peasey A., Bobak M., Kubinova R., Malyutina S., et al. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: Rationale and design of the HAPIEE study // BMC Public Health. 2006. Vol. 18, N.6. P. 255-265.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Rydén L., Grant P. J., Anker S. D., Berne Ch., et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD // European Heart Journal. 2013. Vol. 34. P. 3035-3087.</mixed-citation><mixed-citation xml:lang="en">Rydén L., Grant P. J., Anker S. D., Berne Ch., et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD // European Heart Journal. 2013. Vol. 34. P. 3035-3087.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rose GA, Blackburn H, Gillim RF, et al. Cardiovascular Survey Methods. 2th ed. Geneva, WHO. 1984. 223 p. (Роуз Дж., Блэкберн Г., Гиллум Р. Ф. и др. Эпидемиологические методы изучения сердечно-сосудистых заболеваний. Женева: ВОЗ. 1984. 223 с.</mixed-citation><mixed-citation xml:lang="en">Rose GA, Blackburn H, Gillim RF, et al. Cardiovascular Survey Methods. 2th ed. Geneva, WHO. 1984. 223 p. (Роуз Дж., Блэкберн Г., Гиллум Р. Ф. и др. Эпидемиологические методы изучения сердечно-сосудистых заболеваний. Женева: ВОЗ. 1984. 223 с.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Chung S., Blackshear J., Shen W. - K. et al. Epidemiology and natural history of atrial fibrillation: clinical implications // JACC. 2001. Vol. 37, N. 2. P. 371-378.</mixed-citation><mixed-citation xml:lang="en">Chung S., Blackshear J., Shen W. - K. et al. Epidemiology and natural history of atrial fibrillation: clinical implications // JACC. 2001. Vol. 37, N. 2. P. 371-378.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Nieuwlaat R., Capucci A., Camm A. J., et al. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation // Eur Heart J. 2005. Vol. 26. P. 2422- 2434.</mixed-citation><mixed-citation xml:lang="en">Nieuwlaat R., Capucci A., Camm A. J., et al. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation // Eur Heart J. 2005. Vol. 26. P. 2422- 2434.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Alonso A., Yin X., Roetker N. S., Magnani J. W., Kronmal R. A., et al. Blood lipids and the incidence of atrial fibrillation: The multi-ethnic study of atherosclerosis and the framingham heart study // JAHA. Vol.3, N.5.e001211.</mixed-citation><mixed-citation xml:lang="en">Alonso A., Yin X., Roetker N. S., Magnani J. W., Kronmal R. A., et al. Blood lipids and the incidence of atrial fibrillation: The multi-ethnic study of atherosclerosis and the framingham heart study // JAHA. Vol.3, N.5.e001211.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">CHA2DS2-VASc Score for Atrial Fibrillation Stroke Risk - URL: http://www.mdcalc.com/cha2ds2- vasc-score-for-atrial-fibrillation-stroke-risk/</mixed-citation><mixed-citation xml:lang="en">CHA2DS2-VASc Score for Atrial Fibrillation Stroke Risk - URL: http://www.mdcalc.com/cha2ds2- vasc-score-for-atrial-fibrillation-stroke-risk/</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Risc Score Calculatore - URL: http://www. framinghamheartstudy.org/risk-functions/atrial-fibrillation/10-year-risk.php</mixed-citation><mixed-citation xml:lang="en">Risc Score Calculatore - URL: http://www. framinghamheartstudy.org/risk-functions/atrial-fibrillation/10-year-risk.php</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
